Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prestige Consumer HealthcarePBH -2.24%69 Days Inventory is 123.06 as of Jun. 2026, which is 19% above its 10-year median of 103.71. GuruFocus rates PBH with a GF Score™ of 69/100 and a GF Value™ of $70.51 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 918 Drug Manufacturers companies, Prestige Consumer Healthcare ranks better than 71.46% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Prestige Consumer Healthcare's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.74.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Prestige Consumer Healthcare's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.66.
Prestige Consumer Healthcare (NYSE:PBH) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Prestige Consumer Healthcare's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Prestige Consumer Healthcare's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Prestige Consumer Healthcare Days Inventory Related Terms
Prestige Consumer Healthcare Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PBH vs BCRX, AMLX, SUPN: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prestige Consumer Healthcare Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Prestige Consumer Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prestige Consumer Healthcare (PBH) has a Days Inventory of 123.06 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Prestige Consumer Healthcare and its competitors. This is 19% above median its historical median of 103.71. Over the past decade, Prestige Consumer Healthcare's Days Inventory has ranged from 91.96 to 117.30. According to the industry distribution chart, Prestige Consumer Healthcare ranks #262 out of 918 companies in the Drug Manufacturers industry, placing it in the top 28.5%.
Is Prestige Consumer Healthcare's Days Inventory too high?
Prestige Consumer Healthcare's current Days Inventory of 123.06 is 19% above median its 10-year median of 103.71. Over the past 10 years, this metric has ranged from a low of 91.96 to a high of 117.30. The Drug Manufacturers industry median Days Inventory is 164.89. Prestige Consumer Healthcare's value of 123.06 is 25.4% below this industry median. Based on the distribution chart, Prestige Consumer Healthcare ranks #262 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Prestige Consumer Healthcare has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prestige Consumer Healthcare's Days Inventory compare to BCRX and AMLX?
According to the Drug Manufacturers industry distribution chart, Prestige Consumer Healthcare ranks #262 out of 918 companies for Days Inventory. This puts Prestige Consumer Healthcare in the upper half of its industry. The industry median Days Inventory is 164.89. Prestige Consumer Healthcare's value of 123.06 is 25.4% below this benchmark. Historically, Prestige Consumer Healthcare's own Days Inventory has ranged from 91.96 to 117.30 over the past decade. While the company's 10-year median is 103.71 vs. the industry median of 164.89, Prestige Consumer Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.89, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prestige Consumer Healthcare's current Days Inventory of 123.06 is 25.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Prestige Consumer Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prestige Consumer Healthcare's current Days Inventory is 123.06, which is 19% above median its own 10-year median of 103.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prestige Consumer Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Prestige Consumer Healthcare (PBH) is currently considered Modestly Undervalued. The stock's GF Value™ is $70.51, compared to a current price of $50.52 — trading 28.4% below its estimated fair value. The current Days Inventory is 123.06, which is 19% above median its 10-year median of 103.71 and 25.4% below the Drug Manufacturers industry median of 164.89. Prestige Consumer Healthcare's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Prestige Consumer Healthcare (PBH), the current Days Inventory is 123.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prestige Consumer Healthcare (PBH) Overvalued in 2026?
Based on GuruFocus' analysis, Prestige Consumer Healthcare stock appears to be undervalued.
The current stock price of $50.52 is trading 28.4% below its estimated GF Value™ of $70.51.
GuruFocus considers Prestige Consumer Healthcare to be Modestly Undervalued.
Key valuation signals for PBH:
Days Inventory: 123.06 (19% above median its 10-year median of 103.71)
GF Value™: $70.51 vs. price of $50.52 (28.4% below fair value)
Industry Position: 25.4% below the Drug Manufacturers median (#262 of 918)
No single metric tells the full story. See the PBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
69GF Score
Get the complete analysis for PBH
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBH has been successfully added to your 
